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Misiones Province in northeastern Argentina is considered to be a region with a high prevalence
of HPV infection and a high mortality rate due to cervical cancer. The reasons for this epidemio-
logical trend are not completely understood. To gain insight into this problem, we explored the
relationship between mitochondrial DNA (mtDNA) ancestry, HPV infection, and development of
cervical lesions/cancer in women from the city of Posadas in Misiones Province.
Methods
Two hundred and sixty-one women, including 92 cases of patients diagnosed with cervical
lesions and 169 controls, were analyzed. mtDNA ancestry was assessed through HVS1
sequencing, while the detection and typing of HPV infection was conducted through nested
multiplex PCR analysis. Multivariate logistic regression was conducted with the resulting
data to estimate the odds ratios (ORs) adjusted by socio-demographic variables.
Results
The study participants showed 68.6% Amerindian, 26.1% European and 5.3% African
mtDNA ancestry, respectively. Multiple regression analysis showed that women with African
mtDNAs were three times more likely to develop a cervical lesion than those with Native
American or European mtDNAs [OR of 3.8 (1.2–11.5) for ancestry and OR of 3.5 (1.0–12.0)
for L haplogroups], although the associated p values were not significant when tested under
more complex multivariate models. HPV infection and the development of cervical lesions/
cancer were significant for all tested models, with the highest OR values for HPV16 [OR of
24.2 (9.3–62.7)] and HPV-58 [OR of 19.0 (2.4–147.7)].
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Conclusion
HPV infection remains a central risk factor for cervical cancer in the Posadas population.
The potential role of African mtDNA ancestry opens a new avenue for future medical associ-
ation studies in multiethnic populations, and will require further confirmation in large-scale
studies.
Introduction
The human papillomavirus (HPV) is a small, nonenveloped virus with a circular double-
stranded DNA genome (of approximately 8 kb) that belongs to the family Papillomaviridae
[1]. It infects stratified squamous epithelia (mucosal and cutaneous), where it can cause neo-
plasias or persist asymptomatically. In particular, HPV genital infections by certain types
(identified as high-risk) can lead to the development of cervical lesions and cervical cancer
[2,3]. Currently, more than sixteen HPV strains are identified as high-risk types (HPV-HR)
for the development of cervical cancer, and are classified as Genus Alpha-Papillomavirus, spe-
cies A6, A7 and A9 [1–3].
Cervical cancer is the second most common female cancer in women aged 15 to 44 from
across the world. Incidence rates vary within different geographic regions, being higher in
Africa than in Europe (27.6 cases per 100,000 vs. 11.4/100,000), and intermediate in the Amer-
icas and Asia (14.9/100,000 and 12.7/100,000 respectively) [4]. These differences have been
attributed to the socio-cultural characteristics of the populations in these regions and the lack
of effective screening programs [4]. However, the genetic background of the host population
may further influence the rate of cervical cancer [5–9].
Since the early 1990s, epidemiological studies addressing the role of “ethnicity” (i.e., genetic
ancestry) in the development of cervical cancer have indicated that African-Americans and
Amerindians (“Latinos or Hispanics”) from the United States are at a higher risk of developing
cervical cancer than “whites” [10, 11]. However, these studies classified populations based on
self-reported origin, surname or skin color [10], characteristics that have been shown to be
poor markers of genetic ancestry in diverse populations of Latin America such as those from
Brazil and Argentina [12, 13]. Moreover, after adjustment by socio-economic status, such asso-
ciations tend to disappear, indicating that social factors (rather than ethnicity or ancestry)
have a more important influence on cervical cancer incidence [10, 14]. For these reasons, the
potential influence of genetic ancestry on the prevalence of cervical cancer within different
populations has not yet been comprehensively addressed.
The analysis of mitochondrial DNA (mtDNA) sequence variation can be used to assess the
maternal genetic ancestry of an individual [15]. The mtDNA is a 16,569-base-pair circular
double-stranded molecule containing 37 genes that play an important role in cellular energy
production and apoptosis [16]. An individual’s mtDNA can be placed in a haplogroup (mater-
nal lineage) based on the set of polymorphisms or single nucleotide polymorphisms (SNPs)
present in its sequence. Based on numerous studies, it is now clear that many haplogroups
originated in specific areas of the world and, thus, predominate in local populations. For exam-
ple, four lineages (L0, L1, L2, and L3) are common in African and African-derived populations
[17], nine (H, I, J, K, T, U, V, W and X) in European populations [18], and eight (A, B, C, D, E,
F, G and M) in Asian populations [19, 20], with four Asian-derived haplogroups (A2, B2, D1
and C1) being specific to Native Americans [21, 22].
mtDNA ancestry, HPV infection and cervical cancer in Argentina
PLOS ONE | https://doi.org/10.1371/journal.pone.0190966 January 12, 2018 2 / 16
(Becas CEDIT - Res. 31/12 to DJS); the Ministerio
de Salud de la Nacio´n (MSAL) Argentina -
Comisio´n Nacional Salud Investiga - Becas ¨Carrillo
- Oñativia¨ (Res. 699/13 to DJS); and CONICET
Argentina (Res. 4838/13 to DJS and Res.
Resolucio´n D No 3993/12 to IB) and Codon-Code
Aligner License Grant - USA (2016). The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
In addition to their phylogeographic histories, there is growing interest in the relationship
between mtDNA haplogroups and the development of various types of female cancers. The
presence of the Amerindian haplogroup D5 has been associated with breast cancer [23], the
European haplogroup UK with vulvar cancer [24], and the Amerindian haplogroup B2 with
cervical cancer [25]. These findings suggest that maternal genetic ancestry could play a role in
the incidence of these diseases.
Similarly, an understanding of matrilineal ancestry is important for assessing disease preva-
lence and susceptibility in Argentina. In Argentina, a large proportion of the population has
Native American ancestry (45% and 70% for the central and northern areas, respectively) fol-
lowed by European (50 to 29%) and African (<3%) ancestry [26, 27]. Nevertheless, the effect
of mitochondrial genetic ancestry on cervical cancer in this country is not currently known.
This is also the case for Misiones Province, which is located in the northeastern tip of
Argentina and shares international borders with Paraguay and Brazil. From an epidemiologi-
cal point of view, this province is considered to be a region with a high prevalence of HPV
infection and mortality rate of cervical carcinoma (33–43% and 12/100,000 individuals, respec-
tively) compared to other areas of the country, such as Buenos Aires (30% and 3/100,000) [28,
29]. Its current population is also the product of generations of intermixing between various
groups, including Native Americans, who originally inhabited this part of South America,
Spanish conquerors, and a large European immigrant population that arrived in the 1930s
[30]. Further admixture has occurred through recent immigration from bordering South
American countries such as Brazil and Paraguay [30].
Despite this complex history, the genetic background of this population has been poorly
studied [31–33]. Moreover, the genetic influences on HPV infection and cervical carcinoma
incidence in the region have not been examined. Therefore, the objective of this study was to
explore the relationship between mtDNA ancestry, HPV infection and the development of cer-
vical lesions and cancer in women from this multiethnic region of northeastern Argentina.
Materials and methods
Ethic statement
This study was conducted with the approval of The Ethics Committee of the Dr. Ramo´n Mada-
riaga Hospital, Posadas, Argentina (Departamento de Docencia e Investigacio´n, Comite´ de
Bioe´tica, Hospital Dr. Ramo´n Madariaga, Posadas, Misiones). All experiments were performed
in compliance with institutional guidelines and in accordance with ethical standards of the
Declaration of Helsinski.
Study design
We conducted a retrospective study of genetic risk factors involved in the development of cer-
vical lesions and cancer in women from Posadas in Misiones Province. The study samples
were obtained from women attending to different health centers and clinics in the city between
2005–14. The study samples were archived at the Laboratorio de Biologı´a Molecular Aplicada
(LaBiMAp) of the Facultad de Ciencias Exactas, Quı´micas y Naturales of the University of Mis-
iones. For each sample, a database containing information about participant age, Pap cytology,
date and the location of the sampling center, healthcare system, nationality and place of resi-
dence was recorded. Information about the HPV status of the participants was retrieved from
the database (n = 128) or assessed in this study (n = 136) (see the “HPV detection and typing”
section below).
All samples from the LaBiMAp were obtained with informed consent in the context of pre-
vious epidemiological studies, with none of them addressing mtDNA characterization [8,29].
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The Ethics Committee of the Dr. Ramo´n Madariaga Hospital, Posadas, Argentina, approved
the use of these biological samples for this study.
Population demographics
Posadas is the capital of Misiones Province and currently has a population of 324,758 people
[34]. Of these, 106,141 are women of reproductive age (more than 19 years old) [34], with the
mortality rate for cervical cancer being 12/100,000 [28]. To date, no systematic survey of
genetic diversity in the inhabitants of this city has been undertaken, and the possible existence
of association between socio-demographic variables and mtDNA ancestry is unknown. Such
associations have been reported for other Latin-American populations, such as that of Uru-
guay [13, 35], and their existence should be addressed, since they could affect the outcome of
genetic association studies [35].
In this study, samples were recruited from health centers located at three locations within
the city, including the Downtown area and the 1st and 2nd Urban Belts. Socio-demographic
variables from each location were not recorded although, based on our own records, we can
briefly describe them as follows. The Downtown area is characterized by private practices,
with the resident population being of upper-middle income status and having health insur-
ance. By contrast, the 1st and 2nd Urban Belts contain the main city hospital and a community
health center (respectively). Both are public health centers with an attending population of
middle-low income status whose members largely lack health insurance. To account for the
potential effect of sample center location, those sociodemographic variables showing associa-
tions with mtDNA ancestry were included in the multivariate analysis of this study (see the
“Association Analysis” section).
Nomenclature
The cytological classifications used in this study were as follows: NILM: negative for intrae-
pithelial lesion and malignancy; L-SIL: low-grade squamous intraepithelial lesion; H-SIL:
high-grade squamous intraepithelial lesion; CIS: carcinoma in situ; and ISCC: invasive squa-
mous cell carcinoma [36]. The notation H-SIL+ was used to group H-SIL + CIS + ISCC
patients.
Study groups
In this study, 134 patients diagnosed with cervical lesions (60 L-SIL, 59 H-SIL and 15 with cer-
vical cancer in situ/invasive) were selected without personal identifiers from the laboratory reg-
istry. They represented about 80% of the patients recorded as HSIL+ for the period between
2005–14. A total of 186 control subjects were selected from the same database, with all of their
samples being acquired during the same period as those of the case patients under conditions
of anonymity. DNAs for the Controls and L-SIL samples were obtained from cervical scrapes,
whereas those for the H-SIL+ group were extracted from biopsies of formalin-fixed, paraffin-
embedded tissues (fixed biopsies). Although the initial sample size was 320 individuals, com-
plete genotyping to estimate mtDNA ancestry was successful in 261 of them (81.6%), which
comprises the final number analyzed in this study (see the “Mitochondrial DNA Analysis”
section).
Mitochondrial DNA analysis
mtDNA haplotypes were defined through direct sequencing of the HVS1 region of the control
region (np 16024–16383). Briefly, the HVS1 was PCR amplified using primers 15977-F
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(5´-CCA CCA TTA GCA CCC AAA GC-3´) and 16552-R (5´-TAA GGG GAA CGT
GTG GGC-3´). Positive amplicons were purified using commercial kits (ADN PuriPrep-GP
kit, Inbio Highway) and directly sequenced using the original primers through sequencing ser-
vices using a Beckman Coulter CEQ 2000XL DNA Analysis System (Cromatida, Argentina). A
total of 320 samples were processed and 280 were positive for mtDNA (87.5%). Of these, qual-
ity sequences were obtained from 261 samples (93.2%). The mtDNA sequences were edited
and aligned using Codon Code aligner software v 3.0.1 (CodonCode Corporation). HVS1 hap-
lotypes were classified into haplogroups by using HaploGrep and Phylotree build 17.0 [37, 38].
mtDNA haplotypes and their haplogroup status are shown in S1 Table. HVS-1 sequences were
deposited in GenBank under accession numbers: KY344532—KY344740.
Human papillomavirus detection and typing
HPV detection was performed using PCR amplification with L1 consensus primers MY09–
MY11 [39]. HPV DNA-positive samples were typed by E6-Nested Multiplex PCR (E6-NMPX)
with cocktails of primers C-1 (high-risk HPVs 16, 18, 31, 45, and 59) and C-2 (high-risk HPVs
33, 56, 52, 58 and low-risk HPVs 6 and 11) [40] to determine the type of strain(s) present in
the samples. Positive samples that were not revealed as positive by E6-NMPX amplification
were left as “HPV undetermined”.
Association analysis
The distribution of mtDNA haplogroups or HPV types between study groups was compared
in contingency tables by using χ2 or two-tailed Fisher exact test for cell counts below five. Simi-
larly, the distribution of mtDNA haplogroups according to socio-demographic variables (age,
sample center location, healthcare system, nationality and place of residence) was tested in
contingency tables (χ2 or two-tailed Fisher exact test), with the exception of age, which was
tested using the Median test. Those variables found to be significant were included in the mul-
tivariate analysis.
Multivariate ordinal logistic regression was used to estimate the OR and 95% confidence
intervals (CIs). For these tests, each variable was classified as follows: (1) Cytological diagnosis,
including three categories of progressive nature [NLIM, LSIL and HSIL+]; (2) mtDNA ances-
try, including three categories [Amerindian, European and African]; (3) mtDNA haplogroups,
which included eight categories (A, B, C, D, HV, JT, UK, L), with haplogroups occurring at a
frequency less than 5% being “clustered” into larger monophyletic clades such as UK, JT, HV
and L (L0, L1, L2 and L3) called “phylogroups”; and (4) HPV types, including 10 categories
[HPV negative, HPV undetermined, HPV6/11, HPV56, HPV58, Multiple Infections, HPV52,
HPV33, other HPV-HR and HPV16], in which those HPVs occurring at frequencies less than
5% were clustered into larger groups (other HPV-HR, including species A7: 18, 45 and 59).
For the analysis, HPV types were tested by ordering them according to their increase in the
OR according to Muñoz et al., 2003 [3]. The final models of analysis included (I) Pap cytology
and HPV infection, (II) Pap cytology and mtDNA ancestry, adjusted by socio-demographic
variables, (III) Pap cytology and mtDNA haplogroups, adjusted by socio-demographic vari-
ables, (IV) Pap cytology, mtDNA ancestry and HPV infection, adjusted by socio-demographic
variables, and (V) Pap cytology, mtDNA haplogroups and HPV infection, adjusted by socio-
demographic variables. Ordered logistic regression produced a unified OR value, taking under
consideration the three progressive stages of Pap cytology. All calculations were made using
Stata 14.0 (StataCorp LLC, Texas, USA, 2015). Forest plots were made using GraphPad Prism
version 7.0d for Mac OS X (GraphPad Software Inc, La Jolla California USA, www.graphpad.
com).
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Results
Study groups
Two hundred and sixty one samples, including 92 cases of patients diagnosed with cervical
lesions (50 L-SIL, 35 H-SIL and 7 cervical cancer in situ/invasive) and 169 control subjects
were analyzed. The average age of the H-SIL+ cases was 32.1 years (age range 20–54 years),
that of the L-SIL cases was 31.5 years (20–50 years), and that of controls was 36.0 years (10–83
years).
Human papillomavirus typing distribution and cervical lesions
A total of 130 samples were identified as positive for HPV (49.8%) and 11 different viral types
(16, 18, 31, 33, 45, 52, 56, 58, 59, 6, 11) were identified in them. HPV infection was higher in
women with cervical lesions (70%) compared to those without lesions (37.9%), a pattern con-
sistent with its role in cervical cancer development. Briefly, HPV16 infection had the highest
frequency among study groups (9.5% of NILM; 22% of L-SILs and 57.1% of H-SIL+), followed
by HPV6/11 (3.0% of NILM; 20% of L-SILs and 16.7% of H-SIL+). Multiple infections (double
and triple) were present in 11.1% of women while 8% of the viral infections remained untyped.
Details about HPV types and their frequencies are shown in Table 1.
The results of the association analysis are shown in Table 2. The highest OR values were
found for HPV16 [OR = 18.3 (7.6–44.3)], HPV58 [OR = 13.8 (2.0–95.4)] and HPV6/11
[OR = 9.3 (2.9–30.0)]. Other significant associations included HPV6/11 [OR = 9.3 (2.9–30.0)]
and other HPV-HR [OR = 5.9 (1.5–22.1)].
Mitochondrial DNA ancestry and socio-demographic variables
The mtDNA ancestry of the study population was 68.6% Amerindian, 26.1% European and
5.3% African in origin, respectively. There were statistically significant differences in mtDNA










HPV positive 64 (37.9) 35 (70.0) 31 (73.8) 130 (49.8) < 0.001
HPV Negative 105 (62.1) 15 (30.0) 11 (26.2) 131 (50.2)
HPV typesb
16 16 (9.5) 11 (22.0) 24 (57.1) 51 (19.5) < 0.001
18 1 (0.6) 5 (10.0) 0 (0.0) 6 (2.3) < 0.001
31 4 (2.4) 3 (6.0) 2 (4.8) 9 (3.4) 0.409
33 10 (5.9) 3 (6.0) 1 (2.4) 14 (5.4) 0.645
45 3 (1.8) 0 (0.0) 0 (0.0) 3 (1.1) 0.438
52 8 (4.7) 2 (4.0) 1 (2.4) 11 (4.2) 0.791
56 13 (7.7) 4 (8.0) 1 (2.4) 18 (6.9) 0.450
58 2 (1.2) 2 (4.0) 2 (4.8) 6 (2.3) 0.257
59 1 (0.6) 3 (6.0) 0 (0.0) 4 (1.5) 0.016
6/11 5 (3.0) 10 (20.0) 11 (16.7) 26 (8.4) < 0.001
Multiple-Infections 13 (7.7) 10 (20.0) 6 (14.3) 29 (11.1) > 0.040
HPV-Undetermined 16 (9.5) 5 (10.0) 0 (0.0) 21 (8.0) > 0.111
ap values for the distribution in a contingency tables (χ2 or fisher exact test). Significant p values are shown in boldface.
bHPV infection counts and frequencies include types in single and multiple infections.
https://doi.org/10.1371/journal.pone.0190966.t001
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ancestry among the study groups, with women having European mtDNAs being more fre-
quently found in the cervical lesion groups (L-SIL and H-SIL+) than those women with Amer-
indian mtDNAs (p<0.05). In addition, we explored the effect of socio-demographic variables
on the mtDNA distribution within this population (Table 3). Notably, mtDNA ancestry was
associated with sample center location, healthcare system and nationality, but not with place of
residence or age. Based on these results, these significant variables were included in a multivar-
iate analysis.
Table 2. Association analysis between HPV infection and development of cervical lesions.
HPV O.R. CI 95% p value
HPV negative 1 Ref
HPV positive 4.0 2.3–6.9 <0.001
HPV typesa
16 18.3 7.6–44.3 <0.001
33 1.3 0.3–5.1 0.696
52 0.6 0.1–5.3 0.667
56 1.5 0.4–5.9 0.582
58 13.8 2.0–95.4 0.008
6/11 9.3 2.9–30.0 <0.001
Others HPV-HRb 5.9 1.5–22.1 0.009
Multiple-Infections 4.5 2.0–10.0 <0.001
HPV-Undetermined 1.1 0.4–3.3 0.840
aOrdered logistic regression for Pap cytology and HPV infection (Model I). Significant associations are shown in
boldface.
bIncluding: HPV18, HPV59, HPV45 (specie A7).
https://doi.org/10.1371/journal.pone.0190966.t002








Pap cytology NILM 130 32 7
LSIL 30 18 2 0.002
HSIL+ 20 17 5
Age Mean 35.1 34.3 32.1
Median 32.5 33.0 32.0 0.619b
SD 11.3 9.3 5.6
Range 18–83 20–66 22–38
Sample Location Downtown 54 51 4
1st Urban Belt 32 8 3 <0.001
2nd Urban Belt 94 8 7
Nationality Argentinian 169 66 11
Others 11 1 3 0.013
Place of Living Posadas 166 62 11
Countryside 3 4 0 0.175
HealthCare System Public 126 16 10
Private 54 51 4 <0.001
Note: Some columns do not add up to the total because of missing data.
ap values for the distribution in a contingency tables (χ2 or fisher exact test). Significant p values are shown in boldface.
bp value for the Median Test.
https://doi.org/10.1371/journal.pone.0190966.t003
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Mitochondrial DNA haplogroups and cervical lesions
We identified 17 different mtDNA haplogroups in the study population, all of which corre-
sponded to the major maternal lineages that have contributed to Argentinean history. These
included A2, B2, C1, D1 (Amerindian), H, HV, I, J, K, T, U, V, X2 (European) and L0, L1, L2,
L3 (African) (S1 Table). mtDNA haplogroups (or phylogroups) with a frequency>5% are
shown in Table 4. There were statistically significant differences in the distribution of Euro-
pean phylogroup JT, which occurred more frequently in the cervical lesions groups (p<0.05).
However, this phylogroup was not found to be associated with the development of cervical
lesions in the adjusted multivariate analysis.
Multivariate logistic regression models
The association between mtDNA ancestry and cervical lesion development was estimated
using logistic regression models adjusted by significant socio-demographic variables (sample
center location, healthcare system and nationality). The results are shown in Fig 1. In this pop-
ulation, women with African maternal ancestry were more likely to develop a cervical lesion
than those having Amerindian or European maternal ancestry, with an OR of 3.8 (1.2–11.5)
and a p value of 0.018. This association remained positive at the level of phylogroup with an
OR of 3.5 (1.0–12.0) for haplogroup L, although the significance of this finding was weak, with
a p value of 0.043. Details about the OR estimates are provided in S2 and S3 Tables.
We ran an additional test that included HPV infection in the regression models (Model IV:
Pap cytology, mtDNA ethnic ancestry and HPV infection, adjusted by socio-demographic var-
iables; and Model V: Pap cytology, mtDNA haplogroups and HPV infection, adjusted by
socio-demographic variables). The results are shown in Fig 2. Both analyses showed that
women carrying African mtDNAs were nearly three times more likely to develop a cervical
lesion than those having Native American or European mtDNAs, with a OR of 3.2 (0.8–12.2)
for Model IV and a OR of 2.5 (0.6–10.7) for Model V, although the associated p values were
not significant (0.085 and 0.229 respectively). Different from mtDNA influence, the develop-
ment of cervical lesion was consistently associated with HPV infection by HPV16 at an OR of










A 37 (21.9) 9 (18.0) 7 (16.7) 53 (20.3) 0.680
B 26 (15.4) 5 (10.0) 6 (14.3) 37 (14.2) 0.631
C 45 (26.6) 11 (22.0) 4 (9.5) 60 (23.0) 0.061
D 21 (12.4) 4 (8.0) 3 (7.1) 28 (10.7) 0.482
Subtotal Amerindian 130 (76.9) 30 (60.0) 20 (47.6) 180 (69.0) <0.001
HV 20 (11.8) 10 (20.0) 7 (16.7) 37 (14.2) 0.306
JT 3 (1.8) 4 (8.0) 5 (11.9) 12 (4.6) 0.009
UK 8 (4.7) 3 (6.0) 4 (9.5) 15 (5.7) 0.489
Subtotal European 32 (18.9) 18 (36.0) 17 (40.5) 67 (25.7) 0.003
Subtotal Africanb 7 (4.1) 2 (4.0) 5 (11.9) 14 (5.4) 0.121
Othersc 2 (1.2) 2 (4.0) 1 (2.4) 5 (1.9) 0.307
Total 169 (100.0) 50 (100.0) 42 (100.0) 261 (100.0)
a p values for the distribution in a contingency tables (χ2 or fisher exact test). Significant p values are shown in boldface.
bHaplogroups L0, L1, L2 and L3.
c Haplogroups I, W and X.
https://doi.org/10.1371/journal.pone.0190966.t004
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24.2 (9.3–62.7), and HPV-58 at an OR of 19.0 (2.4–147.7), among other types, across all tested
models (Fig 2). Details about the OR estimates are provided in S4 and S5 Tables.
Discussion
Multi-ethnic populations offer an opportunity to test the effects of ancestry on disease within
the same population [41]. Based on historical records, the population of Posadas was a suitable
candidate with which to use this approach, although its genetic composition was not well
known. This study revealed considerable maternal genetic diversity in the Posadas population,
with 68.6% of the participants having Amerindian, 26.1% European and 5.3% African
mtDNAs, respectively. This general genetic profile is similar to that previously reported for
northeastern Argentina [26, 27], but differed from the reported national average and from that
of larger cities in Argentina such as La Plata and Co´rdoba (with an European component of
nearly 50%) [42, 43]. Overall, the genetic structure within the country is an important issue for
future nationwide medical studies.
Moreover, there is growing evidence that mtDNA variation is deeply structured in world-
wide populations and also more susceptible to false-positive findings in association studies
Fig 1. Multivariate regression analysis for mtDNA and cervical cancer. Legend: A Forest Plot showing odds ratio
values and 95% confidence intervals for: (A) Model II—Pap cytology and mtDNA ancestry, adjusted by socio-
demographic variables and, (B) Model III—Pap cytology and mtDNA haplogroups, adjusted by socio-demographic
variables. The x-axis represents the odds ratio (circles and square) and 95% confidence intervals (whiskers). The
dashed vertical line indicates an OR value of 1. Non-significant values are shown as a small circle. Significant values are
shown as square, with the OR (CI95%) as a legend into the figure. Details on other OR (CI = 95%) and p values are
provided in the Supplementary Information (S2 and S3 Tables). Amerindian ancestry and haplogroup A were not
plotted since they were used as reference values (OR = 1).
https://doi.org/10.1371/journal.pone.0190966.g001
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than autosomal SNPs [44, 45]. In this regard, we observed significant differences between the
maternal lineage distribution and several socio-demographic variables (sample center location,
healthcare system and nationality), a feature shared with other Latin American populations
[12, 35]. Hence, controlling these variables through the use of adjusted ORs and multivariate
analysis was necessary to reduce potential false positives.
In Argentina, there are no previous reports on the relationship between mtDNA ancestry
and cervical cancer, and only three publications have addressed this issue in the published lit-
erature [25, 46, 47]. Among them, the risk of developing cervical cancer has been linked to
Amerindian haplogroup B2 in Mexico [OR 1.6 (1.05–2.58)] [25], to Asian haplogroup M in
Fig 2. Multivariate regression analysis for mtDNA, HPV infection and cervical cancer. Legend: A Forest Plot
showing the odds ratio values and 95% confidence intervals for: (A) Model IV—Pap cytology, mtDNA ancestry and
HPV infection, adjusted by socio-demographic variables and (B) Model V—Pap cytology, mtDNA haplogroups and
HPV infection, adjusted by socio-demographic variables. The x-axis represents the odds ratio (circles, square, others)
and 95% confidence intervals (whiskers). The dashed vertical line indicates the OR value of 1. Non-significant values
are shown as a small filled circle. Significant values are shown as squares (HPV33), diamonds (other HPV-HR),
asterisks (HPV58), triangles (HPV16), inverted triangles (HPV6/11), and unfilled circles (multiple infections), with the
OR (CI = 95%) as a legend into the figure. Details about other OR (CI = 95%) and p values are provided in the
Supplementary Information (S4 and S5 Tables). Amerindian ancestry and haplogroup A were not plotted since they
were used as a reference values.
https://doi.org/10.1371/journal.pone.0190966.g002
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India (OR not provided, but the marker showed a frequency of 65% in cases and 16% in con-
trols) [47], and to Asian-American haplogroup D4 in China [OR 1.034 (1.004–1.006)] [47], but
the latter value is questionable as a risk factor (usually OR>1.5). In the present study, none of
those haplogroups (B2, M or D4) were identified as risk factors for the development of cervical
lesions in Posadas. Instead, we observed an association with African ancestry [OR of 3.8 (1.3–
11.3)] or phylogroup L [OR of 3.8 (1.3–11.3)]. However, this association did not remain signifi-
cant when tested under more complex multivariate models (including HPV infection, mtDNA
and cervical lesions). The latter finding adds a note of caution when interpreting African ances-
try as a candidate factor for cervical cancer development. Moreover, we were actually under-
powered when carrying out the test of interaction between viral and mitochondrial markers.
An additional study limitation was the unsuccessful mtDNA typing in 18.4% of the samples,
a value above the usual threshold of 5–10%. The result can be attributed to the use of DNA
from formalin-fixed, paraffin-embedded tissue in the group of H-SIL+ samples. This source of
DNA has been reported to have a lower DNA quality/quantity compared to cervical scrapes,
due to several potential problems including DNA cross-linking, DNA fragmentation and the
presence of PCR inhibitors [48, 49]. Some studies have further indicated that the length of
DNA fragments might be an important factor, reporting difficulties with amplicons >300 bp
in size [50]. In our study, the amplicon size of the mtDNA HVS-1 was 575 bp, suggesting it
may have been a limiting factor in fixed biopsies samples. Thus, future studies with improved
protocols and larger sample sizes will be needed to confirm our findings.
Nevertheless, epidemiological data derived from US cancer registries indicated that African
Americans, referred to as ‘black’ in them, have a higher incidence of cervical cancer and a
lesser survival rate from all combined malignancies relative to individuals of the ‘white’ popu-
lation [51]. These differences were historically attributed to confounding socio-economical
and behavioral factors, such as diet, alcohol abuse, smoking, and access to screening and treat-
ment. However, there is evidence that the survival disparity persists after normalization for
these factors [52]. Additional epidemiological data show a better outcome in cancer patients
with Hispanic versus African-American background, in spite of comparable socioeconomic
status, a phenomenon known as the ‘Hispanic paradox’ [53]. Differences in lifestyles, specifi-
cally diet, have been proposed as a possible explanation for this observation [53], although
genetic factors may be involved.
Our results may help to provide new working hypotheses about these risk factors. Argen-
tina is an area of considerable interest in this respect, as blacks have historically contributed to
its population but today are not phenotypically “visible” in its inhabitants [54]. As a result, it is
not possible to classify an individual as having African descendant based on morphological
characteristics alone [54]. This fact makes them different from African descendants from the
United States, or those from other Latin American countries like Brazil or Colombia [55, 56].
As a final note, the African genetic component in this study population was higher than the
nationwide average of 2% [26, 27]. This observation can be attributed to the geographic prox-
imity of Misiones to Brazil, a country with a significant African genetic component in its popu-
lation [56]. Misiones Province shares nearly 65% of its boundary with Brazil and has more
than ten international crossing borders that allowed migration between both countries [57]. In
addition, the origin of African descendants in Misiones can be traced back to colonial times
(18th-19th centuries), when African slaves from Brazil escaped by crossing the Uruguay River
and hiding themselves in the forest of Misiones in search of freedom. In addition, the War of
the Triple Alliance (1865–1870) involved soldiers of Afro-Brazilian origin, with some remain-
ing in Posadas after the end of the war. From 1900 onward, African descendants from Brazil
migrated to Misiones as a product of the dynamic socio-political and economical situation of
the two bordering countries [58].
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In spite of these historical records, the 2010 census indicated that only 0.3% of individuals
from the Misiones population consider themselves to be African descendants [59]. However,
this study has some limitations when extrapolating the patterns of genetic diversity to popula-
tions as a whole, as it only provides a view of female genetic history (as inferred from the
mtDNA). In Argentina, the use of different markers (Y chromosome, AIMs, mtDNA) usually
provides different proportions of geographic ancestry, while also indicating a sex-bias in the
contribution coming from the different source populations [26, 43]. Nevertheless, we have
shown that African genes (markers) can be traced in the Argentinean gene pool, and indicated
the potential association between African ancestry and cervical cancer, emphasizing the
importance of taking African genetic variation into account in future association studies.
Different from the mtDNA results, HPV infection was strongly associated with the develop-
ment of cervical lesions for all the tested models, a finding that highlights the biological mean-
ing of such an association.
Conclusion
We have characterized the genetic ancestry of a population from Posadas in Misiones Prov-
ince, northeastern Argentina, and identified a potential association between African mtDNA
ancestry and cervical cancer, a result that will require future replication in an independent
larger sample. HPV infection remains a central risk factor for cervical cancer in Posadas popu-
lation, a finding that is of utmost importance in the vaccine era.
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